Charles Schwab’s Omega Protein OME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-91,594
| Closed | -$1.53M | – | 3075 |
|
|
2017
Q3 | $1.53M | Buy |
91,594
+4,891
| +6% | +$79.5K | ﹤0.01% | 2373 |
|
|
2017
Q2 | $1.55M | Buy |
86,703
+532
| +0.6% | +$9.94K | ﹤0.01% | 2310 |
|
|
2017
Q1 | $1.73M | Sell |
86,171
-19,294
| -18% | -$449K | ﹤0.01% | 2252 |
|
|
2016
Q4 | $2.64M | Buy |
105,465
+34,494
| +49% | +$815K | ﹤0.01% | 2054 |
|
|
2016
Q3 | $1.66M | Buy |
70,971
+37,571
| +112% | +$883K | ﹤0.01% | 2225 |
|
|
2016
Q2 | $668K | Hold |
33,400
| – | – | ﹤0.01% | 2490 |
|
|
2016
Q1 | $566K | Hold |
33,400
| – | – | ﹤0.01% | 2535 |
|
|
2015
Q4 | $742K | Hold |
33,400
| – | – | ﹤0.01% | 2493 |
|
|
2015
Q3 | $567K | Sell |
33,400
-18,831
| -36% | -$293K | ﹤0.01% | 2574 |
|
|
2015
Q2 | $719K | Sell |
52,231
-163,979
| -76% | -$2.18M | ﹤0.01% | 2550 |
|
|
2015
Q1 | $2.96M | Sell |
216,210
-18,629
| -8% | -$215K | ﹤0.01% | 1847 |
|
|
2014
Q4 | $2.48M | Buy |
234,839
+40,019
| +21% | +$474K | ﹤0.01% | 1888 |
|
|
2014
Q3 | $2.44M | Sell |
194,820
-7,620
| -4% | -$106K | ﹤0.01% | 1848 |
|
|
2014
Q2 | $2.77M | Buy |
202,440
+7,500
| +4% | +$98K | ﹤0.01% | 1797 |
|
|
2014
Q1 | $2.35M | Buy |
194,940
+108,860
| +126% | +$1.25M | ﹤0.01% | 1861 |
|
|
2013
Q4 | $1.06M | Buy |
86,080
+60,180
| +232% | +$706K | ﹤0.01% | 2242 |
|
|
2013
Q3 | $250K | Hold |
25,900
| – | – | ﹤0.01% | 2844 |
|
|
2013
Q2 | $238K | Buy |
+25,900
| New | +$261K | ﹤0.01% | 2827 |
|
Charles Schwab's OME Position: Q4 2017 in Review
Charles Schwab sold out of Omega Protein (OME) in Q4 2017, closing a stake of 91,594 shares — an estimated $1.53M sold.
Charles Schwab first reported a position in OME in Q2 2013 and held it in 18 quarters. The position peaked at $2.96M in Q1 2015. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.
- Charles Schwab reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
- Charles Schwab sold 91,594 Omega Protein shares in Q4 2017, an estimated $1.53M.
- Charles Schwab first reported a position in Omega Protein in Q2 2013 and held it in 18 quarters.
- Charles Schwab's Omega Protein position peaked at $2.96M in Q1 2015.
- 0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.
Based on Charles Schwab's 13F filing for Q4 2017, filed 17 Jan 2018.